Company news
Intellia Therapeutics, Inc. news in 2019
Intellia Therapeutics, Inc.'s news releases, calls and decks from 2019, newest first.
Intellia Therapeutics to Present at Evercore ISI 2nd Annual HealthCONx Conference
November 25, 2019
Intellia Therapeutics Announces Third Quarter 2019 Financial Results
October 30, 2019
Intellia Therapeutics to Hold Conference Call to Discuss Third Quarter 2019 Earnings and Company Update
October 23, 2019
Intellia Therapeutics Presents In Vivo and Ex Vivo Data at the 2019 Annual Congress of the European Society of Gene and Cell Therapy (ESGCT)
October 23, 2019
Intellia Therapeutics Announces Presentations at the 2019 Annual Congress of the European Society of Gene and Cell Therapy (ESGCT)
October 15, 2019
Arbitration Decision Affirms Intellia Therapeutics’ Interpretation of Licensing Agreement with Caribou Biosciences on the CRISPR/Cas9 Technology
September 25, 2019
Decks in 2019
- Technical Presentation (May 2019)
Technical · 14 slides · May 2, 2019
- American Society of Gene and Cell Therapy 22nd Annual Meeting (April 2019)
Conference · 15 slides · Apr 29, 2019
- Investor Presentation (January 2019)
Investor deck · 25 slides · Jan 7, 2019